We work to improve the quality of life for those affected by schizophrenia and psychosis through education, support programs, influencing public policy, and encouraging research.
As a continuation of two previous postings on this blog (1, 2), the latest issue of Psychiatric News has an article written by Jim Rosack on the latest "Clinical Antipsychotic Trials of Intervention Effectiveness" (CATIE) results.
No comments:
Post a Comment